URN:NBN:SI:DOC-B1EJX9KH2012Kores-Plesničar, BlankaPlesničar, Andrejdocuments/doc/B/URN_NBN_SI_doc-B1EJX9KH_001.htmdocuments/doc/B/URN_NBN_SI_doc-B1EJX9KH_001.pdfdocuments/doc/B/URN_NBN_SI_doc-B1EJX9KH_001.txt819articlestr. 645-6521318-034730186457URN:NBN:SI:doc-B1EJX9KHslvSlovensko zdravniško društvoZdravniški vestnikBY-NCAdverse EffectsAntineoplastic AgentsAntineoplastikiCognition DisordersDejavniki tveganjaDrug TherapyNeoplasmsNovotvorbeRisk FactorsSpoznavne motnjetumorCancer chemotherapy and cognitive dysfunctionKemoterapija raka in kognitivne motnje